Matching Items (2)
Filtering by

Clear all filters

Description
The need to fully understand the possible consequences of young-adult cannabis use has become increasingly critical as a result of major cannabis policy changes. The purpose of this study was to determine if young-adult users exhibit cognitive deficits on laboratory-based tests and memory and attention deficits in everyday life. Participants

The need to fully understand the possible consequences of young-adult cannabis use has become increasingly critical as a result of major cannabis policy changes. The purpose of this study was to determine if young-adult users exhibit cognitive deficits on laboratory-based tests and memory and attention deficits in everyday life. Participants were 152 students from a large U.S. university enrolled in introductory psychology courses and the top and bottom 10% of the 12-item Yale University PRIME Screening Test for psychotic-like experiences. Participants were asked about their cannabis use and were given six cognitive tests spanning executive function and memory. To test functional impairment in memory and attention, participants were asked to nominate informants (people who knew them well) and these rated the participants on an attention problems scale of four items and a memory problems scale of three items. Results showed that individuals who used cannabis more frequently were rated as having more attention and memory problems and that, consistent with prior research, more frequent cannabis use was associated with worse memory test performance, though the association was not present between frequency of use and executive function test performance. Additionally, it was found that informant-reported attention problems were associated with poorer performance on two of the executive function cognitive tests. The present findings suggest that individuals who use cannabis more frequently experience noticeable memory and attention problems in everyday life, despite the lack of significant correlation between this functional impairment and cognitive test performance. Informant reports, therefore, may be useful in future research for understanding or predicting cognitive impairment in young adults.
ContributorsCarbajal, Lucia (Author) / Meier, Madeline (Thesis director) / McClure, Samuel (Committee member) / Department of Psychology (Contributor) / School of Molecular Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-12
Description

Survivors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often experience chronic symptoms that include fatigue, shortness of breath, and brain fog. The collection of ongoing post-COVID-19 symptoms have been classified as Post-Acute Sequela of SARS-CoV-2 (PASC). Older adult patients are especially susceptible to experiencing PASC related complications and have

Survivors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often experience chronic symptoms that include fatigue, shortness of breath, and brain fog. The collection of ongoing post-COVID-19 symptoms have been classified as Post-Acute Sequela of SARS-CoV-2 (PASC). Older adult patients are especially susceptible to experiencing PASC related complications and have a high risk for long-term cognitive impairment symptoms. Definitions for categorizing PASC- associated cognitive impairment and neuropsychological assessments used to evaluate cognitive impairment are inconsistent between studies examining older adults. This systematic review aims to identify which neuropsychological tests best identify cognitive impairments associated with PASC and suggest a guide to standardize the measurement of PASC-related cognitive impairments. Through a literature search using PubMed, we included within this review 14 studies that fulfilled our inclusion and exclusion criteria evaluating middle-aged and older adult populations affected by PASC-associated cognitive impairments. The majority of the studies used tests designed to screen for general cognitive function to test for the prevalence of cognitive impairment, with the most common one being Montreal Cognitive Assessment (MoCA), followed by MMSE and TICS. MoCA reported the highest prevalence of the general cognitive screeners which suggests higher sensitivity and specificity. Telephone Interview for Cognitive Status (TICS) demonstrated similar scores as MoCA despite administration being remote while MMSE identified the lowest prevalence. Four studies also used domain-specific cognitive evaluations and reported instances of cognitive impairment in individuals who had previously tested healthy. Furthermore, the results gathered in this review were stratified based on disease symptom severity. This review identifies MoCA to be better suited for evaluating general cognitive impairment in older adults. TICS has the added utility in being able to access a wider range of older adults through remote screening. Disease severity must be clearly defined to allow better comparisons between studies and allow for standardization. Early identification of PASC-associated cognitive impairment in middle-aged and older adults can be performed using general cognitive function evaluations and administering a baseline cognitive evaluation one month after infection is suggested.

ContributorsCuc, Nicklus (Author) / Ng, Ted (Thesis director) / Maxfield, Molly (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / Department of Psychology (Contributor)
Created2023-05